Skip to main content
Journal cover image

Epoxyeicosatrienoic acids are involved in the C70 fullerene derivative-induced control of allergic asthma

Publication ,  Journal Article
Norton, SK; Wijesinghe, DS; Dellinger, A; Sturgill, J; Zhou, Z; Barbour, S; Chalfant, C; Conrad, DH; Kepley, CL
Published in: Journal of Allergy and Clinical Immunology
January 1, 2012

Background: Fullerenes are molecules being investigated for a wide range of therapeutic applications. We have shown previously that certain fullerene derivatives (FDs) inhibit mast cell (MC) function in vitro, and here we examine their in vivo therapeutic effect on asthma, a disease in which MCs play a predominant role. Objective: We sought to determine whether an efficient MC-stabilizing FD (C70-tetraglycolate [TGA]) can inhibit asthma pathogenesis in vivo and to examine its in vivo mechanism of action. Methods: Asthma was induced in mice, and animals were treated intranasally with TGA either simultaneously with treatment or after induction of pathogenesis. The efficacy of TGA was determined through the measurement of airway inflammation, bronchoconstriction, serum IgE levels, and bronchoalveolar lavage fluid cytokine and eicosanoid levels. Results: We found that TGA-treated mice have significantly reduced airway inflammation, eosinophilia, and bronchoconstriction. The TGA treatments are effective, even when given after disease is established. Moreover, we report a novel inhibitory mechanism because TGA stimulates the production of an anti-inflammatory P-450 eicosanoid metabolites (cis-epoxyeicosatrienoic acids [EETs]) in the lung. Inhibitors of these anti-inflammatory EETs reversed TGA inhibition. In human lung MCs incubated with TGA, there was a significant upregulation of CYP1B gene expression, and TGA also reduced IgE production from B cells. Lastly, MCs incubated with EET and challenged through FcεRI had a significant blunting of mediator release compared with nontreated cells. Conclusion: The inhibitory capabilities of TGA reported here suggest that FDs might be used a platform for developing treatments for asthma. © 2012 American Academy of Allergy, Asthma & Immunology.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Journal of Allergy and Clinical Immunology

DOI

EISSN

1097-6825

ISSN

0091-6749

Publication Date

January 1, 2012

Volume

130

Issue

3

Related Subject Headings

  • Allergy
  • 3204 Immunology
  • 1107 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Norton, S. K., Wijesinghe, D. S., Dellinger, A., Sturgill, J., Zhou, Z., Barbour, S., … Kepley, C. L. (2012). Epoxyeicosatrienoic acids are involved in the C70 fullerene derivative-induced control of allergic asthma. Journal of Allergy and Clinical Immunology, 130(3). https://doi.org/10.1016/j.jaci.2012.04.023
Norton, S. K., D. S. Wijesinghe, A. Dellinger, J. Sturgill, Z. Zhou, S. Barbour, C. Chalfant, D. H. Conrad, and C. L. Kepley. “Epoxyeicosatrienoic acids are involved in the C70 fullerene derivative-induced control of allergic asthma.” Journal of Allergy and Clinical Immunology 130, no. 3 (January 1, 2012). https://doi.org/10.1016/j.jaci.2012.04.023.
Norton SK, Wijesinghe DS, Dellinger A, Sturgill J, Zhou Z, Barbour S, et al. Epoxyeicosatrienoic acids are involved in the C70 fullerene derivative-induced control of allergic asthma. Journal of Allergy and Clinical Immunology. 2012 Jan 1;130(3).
Norton, S. K., et al. “Epoxyeicosatrienoic acids are involved in the C70 fullerene derivative-induced control of allergic asthma.” Journal of Allergy and Clinical Immunology, vol. 130, no. 3, Jan. 2012. Scopus, doi:10.1016/j.jaci.2012.04.023.
Norton SK, Wijesinghe DS, Dellinger A, Sturgill J, Zhou Z, Barbour S, Chalfant C, Conrad DH, Kepley CL. Epoxyeicosatrienoic acids are involved in the C70 fullerene derivative-induced control of allergic asthma. Journal of Allergy and Clinical Immunology. 2012 Jan 1;130(3).
Journal cover image

Published In

Journal of Allergy and Clinical Immunology

DOI

EISSN

1097-6825

ISSN

0091-6749

Publication Date

January 1, 2012

Volume

130

Issue

3

Related Subject Headings

  • Allergy
  • 3204 Immunology
  • 1107 Immunology